Intrinsic Value of S&P & Nasdaq Contact Us

HOOKIPA Pharma Inc. HOOK OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+171.5%

HOOKIPA Pharma Inc. (HOOK) has 20 known insider and institutional holders on record. The largest holder is GILEAD SCIENCES, INC. with 18,759,465 shares. Other notable holders include GILEAD SCIENCES INC and SOFINNOVA CAPITAL VI FCPR.

HOOK Insider Ownership

Top Holder
GILEAD SCIENCES, INC.
18,759,465 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Gilead Sciences, Inc. 10 Percent Owner 18,759,465 2023-12-22
100%
2 Gilead Sciences Inc 10 Percent Owner 3,759,465 2022-02-17
20%
3 Sofinnova Capital Vi Fcpr 10 Percent Owner 3,177,574 2021-04-23
17%
4 Aldag Jorn Chief Executive Officer 971,400 2024-04-17
5%
5 Boyle Timothy P Director 452,842 2008-07-03
2%
6 Kandera Reinhard Chief Financial Officer 406,200 2024-04-17
2%
7 Necina Roman Chief Operations Officer 367,300 2024-04-17
2%
8 Orlinger Klaus Chief Scientific Officer 367,300 2024-04-17
2%
9 Baker Christine D. Chief Operating Officer 275,800 2023-04-18
1%
10 Schlienger Katia Chief Medical Officer 184,000 2023-04-18
1%
11 Pinschewer David Chief Scientific Officer 116,416 2019-04-24
1%
12 Peters Malte Chief Executive Officer 108,695 2024-07-24
1%
13 Van De Winkel Jan Director 98,000 2024-06-18
1%
14 Matushansky Igor Chief Medical Officer 92,950 2022-07-01
0%
15 Coelho Mary Theresa EVP and CFO 69,875 2024-07-24
0%
16 Winderlich Mark Chief Development Officer 50,000 2024-04-17
0%
17 O'neill Julie Director 49,000 2024-06-18
0%
18 Kaufman David Ross Director 49,000 2024-06-18
0%
19 Reilly Timothy P. Director 49,000 2024-06-18
0%
20 Lilja Anders Sr. VP, Technical Development 42,784 2019-04-24
0%

No ownership data available for HOOK.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message